BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1329 related articles for article (PubMed ID: 27283160)

  • 21. Evaluation of statistical methods used to meta-analyse results from interrupted time series studies: A simulation study.
    Korevaar E; Turner SL; Forbes AB; Karahalios A; Taljaard M; McKenzie JE
    Res Synth Methods; 2023 Nov; 14(6):882-902. PubMed ID: 37731166
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A robust interrupted time series model for analyzing complex health care intervention data.
    Cruz M; Bender M; Ombao H
    Stat Med; 2017 Dec; 36(29):4660-4676. PubMed ID: 28850683
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Segmented Regression and Difference-in-Difference Methods: Assessing the Impact of Systemic Changes in Health Care.
    Mascha EJ; Sessler DI
    Anesth Analg; 2019 Aug; 129(2):618-633. PubMed ID: 31008746
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Design and analysis of two groups interrupt time series].
    Li Y; Yu SC; Jin CG; Yang MJ; Ma XJ; Wang QQ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2019 Sep; 40(9):1159-1163. PubMed ID: 31594165
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Methods used to meta-analyse results from interrupted time series studies: A methodological systematic review protocol.
    Korevaar E; Karahalios A; Forbes AB; Turner SL; McDonald S; Taljaard M; Grimshaw JM; Cheng AC; Bero L; McKenzie JE
    F1000Res; 2020; 9():110. PubMed ID: 33163155
    [No Abstract]   [Full Text] [Related]  

  • 26. Comparison of statistical methods used to meta-analyse results from interrupted time series studies: an empirical study.
    Korevaar E; Turner SL; Forbes AB; Karahalios A; Taljaard M; McKenzie JE
    BMC Med Res Methodol; 2024 Feb; 24(1):31. PubMed ID: 38341540
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A reanalysis of cluster randomized trials showed interrupted time-series studies were valuable in health system evaluation.
    Fretheim A; Zhang F; Ross-Degnan D; Oxman AD; Cheyne H; Foy R; Goodacre S; Herrin J; Kerse N; McKinlay RJ; Wright A; Soumerai SB
    J Clin Epidemiol; 2015 Mar; 68(3):324-33. PubMed ID: 25499983
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Methodological considerations for interrupted time series analysis in radiation epidemiology: an overview.
    Wollschläger D; Auvinen A; Blettner M; Zeeb H
    J Radiol Prot; 2021 Sep; 41(4):. PubMed ID: 34261051
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In praise of Prais-Winsten: An evaluation of methods used to account for autocorrelation in interrupted time series.
    Bottomley C; Ooko M; Gasparrini A; Keogh RH
    Stat Med; 2023 Apr; 42(8):1277-1288. PubMed ID: 36722328
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Segmented regression analysis of interrupted time series data to assess outcomes of a South American road traffic alcohol policy change.
    Nistal-Nuño B
    Public Health; 2017 Sep; 150():51-59. PubMed ID: 28624588
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Methodological Progress Note: Interrupted Time Series.
    Mahant S; Hall M
    J Hosp Med; 2021 Jun; 16(6):364-367. PubMed ID: 34129489
    [No Abstract]   [Full Text] [Related]  

  • 32. Controlling for seasonal patterns and time varying confounders in time-series epidemiological models: a simulation study.
    Perrakis K; Gryparis A; Schwartz J; Le Tertre A; Katsouyanni K; Forastiere F; Stafoggia M; Samoli E
    Stat Med; 2014 Dec; 33(28):4904-18. PubMed ID: 25052462
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Validity of the Comparative Interrupted Time Series Design for Evaluating the Effect of School-Level Interventions.
    Jacob R; Somers MA; Zhu P; Bloom H
    Eval Rev; 2016 Jun; 40(3):167-198. PubMed ID: 27553034
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Segmented regression analysis of interrupted time series studies in medication use research.
    Wagner AK; Soumerai SB; Zhang F; Ross-Degnan D
    J Clin Pharm Ther; 2002 Aug; 27(4):299-309. PubMed ID: 12174032
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effectiveness of the non-pharmaceutical public health interventions against COVID-19; a protocol of a systematic review and realist review.
    Iezadi S; Azami-Aghdash S; Ghiasi A; Rezapour A; Pourasghari H; Pashazadeh F; Gholipour K
    PLoS One; 2020; 15(9):e0239554. PubMed ID: 32991604
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Methods, applications, interpretations and challenges of interrupted time series (ITS) data: protocol for a scoping review.
    Ewusie JE; Blondal E; Soobiah C; Beyene J; Thabane L; Straus SE; Hamid JS
    BMJ Open; 2017 Jul; 7(6):e016018. PubMed ID: 28674142
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An improved method for analysis of interrupted time series (ITS) data: accounting for patient heterogeneity using weighted analysis.
    Ewusie J; Beyene J; Thabane L; Straus SE; Hamid JS
    Int J Biostat; 2022 Nov; 18(2):521-535. PubMed ID: 34473922
    [TBL] [Abstract][Full Text] [Related]  

  • 38. RITS: a toolbox for assessing complex interventions via interrupted time series models.
    Cruz M; Pinto-Orellana MA; Gillen DL; Ombao HC
    BMC Med Res Methodol; 2021 Jul; 21(1):143. PubMed ID: 34238221
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The impact of the congestion charging scheme on air quality in London. Part 1. Emissions modeling and analysis of air pollution measurements.
    Kelly F; Anderson HR; Armstrong B; Atkinson R; Barratt B; Beevers S; Derwent D; Green D; Mudway I; Wilkinson P;
    Res Rep Health Eff Inst; 2011 Apr; (155):5-71. PubMed ID: 21830496
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Respiratory virus surveillance in Canada during the COVID-19 pandemic: An epidemiological analysis of the effectiveness of pandemic-related public health measures in reducing seasonal respiratory viruses test positivity.
    Park KY; Seo S; Han J; Park JY
    PLoS One; 2021; 16(6):e0253451. PubMed ID: 34143839
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 67.